Literature DB >> 19212846

Circadian intraocular pressure rhythms in athletic horses under different lighting regime.

Cristiano Bertolucci1, Elisabetta Giudice, Francesco Fazio, Giuseppe Piccione.   

Abstract

The present study was undertaken to investigate the existence of intraocular pressure (IOP) rhythms in athletic thoroughbred horses maintained under a 24 h cycle of light and darkness (LD) or under constant light (LL) or constant dark (DD) conditions. We identified an IOP circadian rhythm that is entrained to the 24 h LD cycle. IOP was low during the dark phase and high during the light phase, with a peak at the end of the light phase (ZT10). The circadian rhythm of IOP persisted in DD (with a peak at CT9.5), demonstrating an endogenous component in IOP rhythm. As previously shown in other mammalian species, horse IOP circadian rhythmicity was abolished in LL. Because tonometry is performed in horses for the diagnosis of ophthalmologic diseases, such as glaucoma or anterior uveitis, the daily variation in IOP must be taken into account in clinical practice to properly time tests and to interpret clinical findings.

Entities:  

Mesh:

Year:  2009        PMID: 19212846     DOI: 10.1080/07420520902751035

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  3 in total

1.  Effects of 0.2% brimonidine and 0.2% brimonidine-0.5% timolol on intraocular pressure and pupil size in normal equine eyes.

Authors:  M Von Zup; M Lassaline; P H Kass; P E Miller; S M Thomasy
Journal:  Equine Vet J       Date:  2017-06-05       Impact factor: 2.888

2.  Ophthalmology of clinically normal alpacas (Vicugna pacos) in the United Kingdom: a cross-sectional study.

Authors:  Josephine Faulkner; David Leonard Williams; Karin Mueller
Journal:  Vet Rec       Date:  2020-04-17       Impact factor: 2.695

3.  Comparison of two rebound tonometers in healthy horses.

Authors:  Minna P Mustikka; Elina M Pietilä; Anna K Mykkänen; Thomas S C Grönthal
Journal:  Vet Ophthalmol       Date:  2020-09-04       Impact factor: 1.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.